Pravastatin conversion to atorvastatin

Size: px
Start display at page:

Download "Pravastatin conversion to atorvastatin"

Transcription

1 P ford residence southampton, ny Pravastatin conversion to atorvastatin Pravastatin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. El hallazgo de las estatinas es una de las manifestaciones que mejor define la moderna farmacología. Inicialmente se definió exactamente la diana terapéutica donde. The API Industry at a Glance: The Active Pharmaceutical Ingredient Industry is the organ by which active pharmaceutical ingredients are manufactured from raw. Learn about Lipitor ( Atorvastatin Calcium) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. Lipitor official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. Lipitor 10mg chewable tablets - Summary of Product Characteristics (SmPC) by Pfizer Limited. Clofibrate

2 (tradename Atromid-S) is an organic compound. It is marketed as a fibrate. It is a lipid-lowering agent used for controlling the high cholesterol and. Atorvastatin 10mg Filmcoated Tablets - Summary of Product Characteristics (SmPC) by Actavis UK Ltd. LIPITOR - atorvastatin calcium trihydrate tablet, film coated Parke-Davis Div of Pfizer Inc Atorvastatin (Lipitor, generics). NA. 10 to 20 mg. Max dose 10 mg, with caution, in patients with a history of renal insufficiency, or CrCl <30 ml/min. (Canada).2. Pravastatin. (Pravachol, generics). 10 to 20 mg. Use an initial dose of 10 mg in patients with a history of significant renal or liver. (Canada) impairment.7,12. Table 5. Statin Dose Intensity and Equivalency Chart*. Statin. Intensity. %LDL- C. Reduction. HMG-CoA Reductase Inhibitor. Rosuvastatin. Atorvastatin. Pitavastatin. Simvastatin. Lovastatin. Pravastatin. Fluvastatin. High-. Intensity. ( lowers. LDL-C. 50%) mg. ($196) mg. ($9 gen, $236 br) Drug. Approximate Equivalent Dose2. Lovastatin (Mevacor ). 40 mg. Pravastatin 1 (Pravachol ). 40 mg. Simvastatin (Zocor ). 20 mg (maximum 40 mg/dose).

3 Atorvastatin1 (Lipitor ). 10 mg. Fluvastatin (Lescol ). 80 mg. Rosuvastatin ( Crestor ). 5 mg. There was a lower incidence of MACE in patients taking pitavastatin versus the other statins (pitavastatin 8.3%, vs. atorvastatin 19.3%, vs. pravastatin 27.2% and... **If a patient is receiving Fluvastatin XL 80 mg daily, conversion to pravastatin 80 mg daily can produce similar reductions in LDL (At 4 weeks, mean change in. Derived from respective Product Package Insert / Drug Class Review: HMG CoA Reductase Inhibitors (Statins) VHA. Pharmacy Benefit Management Strategic Healthcare Group and the Medical Advisory Panel. White Zone- Available Generically. Black Zone - Brands that have dose equivalent generics available WILL. STATIN CONVERSION CHART. DIRTIT. % LDL. Reduction. <24% % % % % % %. Simvastatin Atorvastatin Rosuvastatin Fluvastatin Lovastatin Pravastatin Ezetimibe/Simvastatin. (Zocor). (Lipitor). ( Crestor). (Lescol). (Mevacor) (Pravachol). (Vytorin). 5 mg. 20 mg. 10 mg. 10 mg. 10 mg. In order to assist in converting your patient from a Non-preferred statin to the

4 Preferred statin on Arkansas. Medicaid, the following chart shows an approximate equivalent daily dose for statins with respect to their LDL-c lowering abilities. To discuss conversion to the Preferred Drug or to request authorization for a Non-. Jul 7, ADVISORY. Crestor to Atorvastatin. Conversion. (Paul Bandfield, PharmD, Formulary Management Services). All strengths of atorvastatin (10, 20, 40 and 80mg) have recently been added to the Commercial formulary. Atorvastatin is on the generic tier for members with a. Commercial HMO benefit and tier. Equivalent Dosages -1. Atorvastatin (Lipitor ): -- (see tablet strengths), Fluvastatin (Lescol ): 20 mg, Lovastatin (Mevacor ): 10 mg. Pravastatin ( Pravachol ): 10 mg, Rosuvastatin (Crestor ): --, Simvastatin (Zocor ): 5 mg. Lovastatin (Merck's Mevacor) is a statin drug, used for lowering cholesterol in those with hypercholesterolemia to reduce risk of cardiovascular disease. Atorvastatin Mylan 10 mg, 20 mg, 40 mg & 80 mg film-coated tablets - Summary of Product Characteristics (SPC) by Gerard Laboratories. Atorvastatin 10 mg Film Coated Tablets - Summary of Product

5 Characteristics (SmPC) by Pfizer Limited. Atorvastatin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. Atorvastatin 60 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Consilient Health Ltd. In order to assist in converting your patient from a Non-preferred statin to the Preferred statin on Arkansas Medicaid, the following chart shows an approximate. Pravastatin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. Learn about Lipitor (Atorvastatin Calcium) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. The API Industry at a Glance: The Active Pharmaceutical Ingredient Industry is the organ by which active pharmaceutical ingredients are manufactured from raw. LIPITOR- atorvastatin calcium trihydrate tablet, film coated Parke-Davis Div of Pfizer Inc The API Industry at a Glance: The Active Pharmaceutical Ingredient Industry is the organ by which active pharmaceutical

6 ingredients are manufactured from raw. El hallazgo de las estatinas es una de las manifestaciones que mejor define la moderna farmacología. Inicialmente se definió exactamente la diana terapéutica donde. Learn about Lipitor ( Atorvastatin Calcium) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. Clofibrate (tradename Atromid-S) is an organic compound. It is marketed as a fibrate. It is a lipid-lowering agent used for controlling the high cholesterol and. Pravastatin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. Atorvastatin 10mg Film-coated Tablets - Summary of Product Characteristics (SmPC) by Actavis UK Ltd. Lipitor official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. LIPITOR - atorvastatin calcium trihydrate tablet, film coated Parke-Davis Div of Pfizer Inc Lipitor 10mg chewable tablets - Summary of Product Characteristics (SmPC) by

7 Pfizer Limited. Atorvastatin (Lipitor, generics). NA. 10 to 20 mg. Max dose 10 mg, with caution, in patients with a history of renal insufficiency, or CrCl <30 ml/min. (Canada).2. Pravastatin. (Pravachol, generics). 10 to 20 mg. Use an initial dose of 10 mg in patients with a history of significant renal or liver. (Canada) impairment.7,12. STATIN CONVERSION CHART. DIRTIT. % LDL. Reduction. <24% % % % % % %. Simvastatin Atorvastatin Rosuvastatin Fluvastatin Lovastatin Pravastatin Ezetimibe/Simvastatin. (Zocor). (Lipitor). ( Crestor). (Lescol). (Mevacor) (Pravachol). (Vytorin). 5 mg. 20 mg. 10 mg. 10 mg. 10 mg. Derived from respective Product Package Insert / Drug Class Review: HMG CoA Reductase Inhibitors (Statins) VHA. Pharmacy Benefit Management Strategic Healthcare Group and the Medical Advisory Panel. White Zone- Available Generically. Black Zone - Brands that have dose equivalent generics available WILL. Equivalent Dosages -1. Atorvastatin (Lipitor ): -- (see tablet strengths), Fluvastatin (Lescol ): 20 mg, Lovastatin (Mevacor ): 10 mg. Pravastatin (

8 Pravachol ): 10 mg, Rosuvastatin (Crestor ): --, Simvastatin (Zocor ): 5 mg. Drug. Approximate Equivalent Dose2. Lovastatin (Mevacor ). 40 mg. Pravastatin 1 (Pravachol ). 40 mg. Simvastatin (Zocor ). 20 mg (maximum 40 mg/dose). Atorvastatin1 (Lipitor ). 10 mg. Fluvastatin (Lescol ). 80 mg. Rosuvastatin ( Crestor ). 5 mg. In order to assist in converting your patient from a Non-preferred statin to the Preferred statin on Arkansas. Medicaid, the following chart shows an approximate equivalent daily dose for statins with respect to their LDL-c lowering abilities. To discuss conversion to the Preferred Drug or to request authorization for a Non-. Jul 7, ADVISORY. Crestor to Atorvastatin. Conversion. (Paul Bandfield, PharmD, Formulary Management Services). All strengths of atorvastatin (10, 20, 40 and 80mg) have recently been added to the Commercial formulary. Atorvastatin is on the generic tier for members with a. Commercial HMO benefit and tier. There was a lower incidence of MACE in patients taking pitavastatin versus the other statins (pitavastatin 8.3%, vs. atorvastatin 19.3%, vs.

9 pravastatin 27.2% and... **If a patient is receiving Fluvastatin XL 80 mg daily, conversion to pravastatin 80 mg daily can produce similar reductions in LDL (At 4 weeks, mean change in. Table 5. Statin Dose Intensity and Equivalency Chart*. Statin. Intensity. %LDL- C. Reduction. HMG-CoA Reductase Inhibitor. Rosuvastatin. Atorvastatin. Pitavastatin. Simvastatin. Lovastatin. Pravastatin. Fluvastatin. High-. Intensity. ( lowers. LDL-C. 50%) mg. ($196) mg. ($9 gen, $236 br) The API Industry at a Glance: The Active Pharmaceutical Ingredient Industry is the organ by which active pharmaceutical ingredients are manufactured from raw. Atorvastatin Mylan 10 mg, 20 mg, 40 mg & 80 mg filmcoated tablets - Summary of Product Characteristics (SPC) by Gerard Laboratories. Pravastatin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. Lovastatin (Merck's Mevacor) is a statin drug, used for lowering cholesterol in those with hypercholesterolemia to reduce risk of cardiovascular disease. In order to assist in converting your patient from a

10 Non-preferred statin to the Preferred statin on Arkansas Medicaid, the following chart shows an approximate. LIPITOR- atorvastatin calcium trihydrate tablet, film coated Parke-Davis Div of Pfizer Inc Atorvastatin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. Learn about Lipitor (Atorvastatin Calcium) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. Atorvastatin 60 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Consilient Health Ltd. Atorvastatin 10 mg Film Coated Tablets - Summary of Product Characteristics (SmPC) by Pfizer Limited. Pravastatin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. Clofibrate (tradename Atromid- S) is an organic compound. It is marketed as a fibrate. It is a lipid-lowering agent used for controlling the high cholesterol and. Lipitor official prescribing information for healthcare professionals. Includes: indications, dosage, adverse

11 reactions, pharmacology and more. Atorvastatin 10mg Filmcoated Tablets - Summary of Product Characteristics (SmPC) by Actavis UK Ltd. Lipitor 10mg chewable tablets - Summary of Product Characteristics (SmPC) by Pfizer Limited. El hallazgo de las estatinas es una de las manifestaciones que mejor define la moderna farmacología. Inicialmente se definió exactamente la diana terapéutica donde. The API Industry at a Glance: The Active Pharmaceutical Ingredient Industry is the organ by which active pharmaceutical ingredients are manufactured from raw. LIPITOR - atorvastatin calcium trihydrate tablet, film coated Parke-Davis Div of Pfizer Inc Learn about Lipitor ( Atorvastatin Calcium) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. Table 5. Statin Dose Intensity and Equivalency Chart*. Statin. Intensity. %LDL- C. Reduction. HMG-CoA Reductase Inhibitor. Rosuvastatin. Atorvastatin. Pitavastatin. Simvastatin. Lovastatin. Pravastatin. Fluvastatin. High-. Intensity. ( lowers. LDL-C. 50%) mg. ($196) mg. ($9 gen, $236 br) Equivalent Dosages -1.

12 Atorvastatin (Lipitor ): -- (see tablet strengths), Fluvastatin (Lescol ): 20 mg, Lovastatin (Mevacor ): 10 mg. Pravastatin ( Pravachol ): 10 mg, Rosuvastatin (Crestor ): --, Simvastatin (Zocor ): 5 mg. STATIN CONVERSION CHART. DIRTIT. % LDL. Reduction. <24% % % % % % %. Simvastatin Atorvastatin Rosuvastatin Fluvastatin Lovastatin Pravastatin Ezetimibe/Simvastatin. (Zocor). (Lipitor). ( Crestor). (Lescol). (Mevacor) (Pravachol). (Vytorin). 5 mg. 20 mg. 10 mg. 10 mg. 10 mg. There was a lower incidence of MACE in patients taking pitavastatin versus the other statins (pitavastatin 8.3%, vs. atorvastatin 19.3%, vs. pravastatin 27.2% and... **If a patient is receiving Fluvastatin XL 80 mg daily, conversion to pravastatin 80 mg daily can produce similar reductions in LDL (At 4 weeks, mean change in. Jul 7, ADVISORY. Crestor to Atorvastatin. Conversion. (Paul Bandfield, PharmD, Formulary Management Services). All strengths of atorvastatin (10, 20, 40 and 80mg) have recently been added to the Commercial formulary. Atorvastatin is on

13 the generic tier for members with a. Commercial HMO benefit and tier. Atorvastatin (Lipitor, generics). NA. 10 to 20 mg. Max dose 10 mg, with caution, in patients with a history of renal insufficiency, or CrCl <30 ml/min. (Canada).2. Pravastatin. (Pravachol, generics). 10 to 20 mg. Use an initial dose of 10 mg in patients with a history of significant renal or liver. (Canada) impairment.7,12. Derived from respective Product Package Insert / Drug Class Review: HMG CoA Reductase Inhibitors (Statins) VHA. Pharmacy Benefit Management Strategic Healthcare Group and the Medical Advisory Panel. White Zone- Available Generically. Black Zone - Brands that have dose equivalent generics available WILL. In order to assist in converting your patient from a Non-preferred statin to the Preferred statin on Arkansas. Medicaid, the following chart shows an approximate equivalent daily dose for statins with respect to their LDL-c lowering abilities. To discuss conversion to the Preferred Drug or to request authorization for a Non-. Drug. Approximate Equivalent Dose2. Lovastatin (Mevacor ). 40 mg. Pravastatin 1 (Pravachol ). 40 mg. Simvastatin (Zocor ). 20

14 mg (maximum 40 mg/dose). Atorvastatin1 (Lipitor ). 10 mg. Fluvastatin (Lescol ). 80 mg. Rosuvastatin ( Crestor ). 5 mg. Atorvastatin 60 mg filmcoated tablets - Summary of Product Characteristics (SmPC) by Consilient Health Ltd. Atorvastatin Mylan 10 mg, 20 mg, 40 mg & 80 mg film-coated tablets - Summary of Product Characteristics (SPC) by Gerard Laboratories. Atorvastatin 10 mg Film Coated Tablets - Summary of Product Characteristics (SmPC) by Pfizer Limited. The API Industry at a Glance: The Active Pharmaceutical Ingredient Industry is the organ by which active pharmaceutical ingredients are manufactured from raw. LIPITOR- atorvastatin calcium trihydrate tablet, film coated Parke-Davis Div of Pfizer Inc Lovastatin (Merck's Mevacor) is a statin drug, used for lowering cholesterol in those with hypercholesterolemia to reduce risk of cardiovascular disease. Learn about Lipitor (Atorvastatin Calcium) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. In order to assist in converting your patient from a Non-preferred statin to the Preferred statin on Arkansas Medicaid, the following chart

15 shows an approximate. Pravastatin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. Atorvastatin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. POST OFFICE BOX 3037 BRIDGEHAMPTON, NEW YORK PHONE: (631) FAX: (631) home ranking importance of items for survival artery roadmap answers prolixin and ativan im compatibility Doctor leaving practice letter to patients Coumadin care plan toriel porn games THIS PAGE WAS LAST UPDATE ON 04/13/01 COPYRIGHT 2000 Pravastatin conversion to atorvastatin ALL RIGHTS RESERVED

Simvastatin 40 mg equivalent

Simvastatin 40 mg equivalent Simvastatin 40 mg equivalent medications equivalent to Simvastatin is available on the Drugs.com website. Simvastatin (Zocor ): 10 mg : Equivalent Dosages - 3: Atorvastatin (Lipitor. 40 mg : Equivalent

More information

Atorvastatin and upper arm pain

Atorvastatin and upper arm pain P ford residence southampton, ny Atorvastatin and upper arm pain Caduet (amlodipine and atorvastatin ) is used to treat high blood pressure or angina in patients with high cholesterol. Includes Caduet

More information

STATIN UTILIZATION MANAGEMENT CRITERIA

STATIN UTILIZATION MANAGEMENT CRITERIA STATIN UTILIZATION MANAGEMENT CRITERIA DRUG CLASS: HMG Co-A Reductase Inhibitors & Combinations Agents which require prior review: Advicor (niacin extended-release/lovastatin) Crestor (rosuvastatin)(5mg,10mg,

More information

Pravastatin conversion to atorvastatin

Pravastatin conversion to atorvastatin Pravastatin atorvastatin 10/28/2017 The wichita horrorcrime scene photos 10/28/2017 Hydrocodone 7.5 325 street value 10/30/2017 -How do you switch from lyrica to gabapentin -1995 colman fleetwood stoney

More information

It is the policy of health plans affiliated with PA Health & Wellness that Vytorin is medically necessary when the following criteria are met:

It is the policy of health plans affiliated with PA Health & Wellness that Vytorin is medically necessary when the following criteria are met: Clinical Policy: Ezetimibe and Simvastatin (Vytorin) Reference Number: PA.CP.PMN.77 Effective Date: 02.01.17 Last Review Date: 07.18 Revision Log Description Ezetimibe/simvastatin (Vytorin ) contains ezetimibe,

More information

Conversion of crestor to lipitor

Conversion of crestor to lipitor Conversion of crestor to lipitor Apr 25, 2018. Atorvastatin (Lipitor ): 10 mg, Fluvastatin (Lescol ): 80 mg, Rosuvastatin. Nov 16, 2011. In a head-to-head test of two popular cholesterol-lowering statin

More information

Conversion from atorvastatin to pravastatin

Conversion from atorvastatin to pravastatin Conversion from pravastatin 04/29/2018 Clever team names for work 04/30/2018 Clomid and implantation bleeding 05/01/2018 -Icd 10 code for radiculopathy lower extremity -Icd 10 for wound vac placement 05/02/2018

More information

Atorvastatin 10 mg cholesterol

Atorvastatin 10 mg cholesterol P ford residence southampton, ny Atorvastatin 10 mg cholesterol Atorvastatin is a cholesterol - lowering medication that blocks the production of cholesterol.. Initial dose: 10 mg to 80 mg orally once

More information

High ( 50%) Restrictions mg 20-40mg PA; TS ⱡ 15 ⱡ

High ( 50%) Restrictions mg 20-40mg PA; TS ⱡ 15 ⱡ MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Cholesterol P&T DATE: 5/9/2017 THERAPEUTIC CLASS: Cardiovascular REVIEW HISTORY: 5/16, 5/15, 2/14, 5/12, LOB AFFECTED: Medi-Cal

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Caduet) Reference Number: CP.CPA.237 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy

More information

Diseases & Conditions

Diseases & Conditions http://my.clevelandclinic.org Diseases & Conditions About Cholesterol-Lowering Drugs Some people have a genetic predisposition to high blood cholesterol levels. These people may need drug therapy in addition

More information

Clinical Policy: Pitavastatin (Livalo), Ezetimibe/Simvastatin (Vytorin 10/10 mg) Reference Number: CP.CPA.62 Effective Date:

Clinical Policy: Pitavastatin (Livalo), Ezetimibe/Simvastatin (Vytorin 10/10 mg) Reference Number: CP.CPA.62 Effective Date: Clinical Policy: Pitavastatin (Livalo), Ezetimibe/Simvastatin (Vytorin 10/10 mg) Reference Number: CP.CPA.62 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See

More information

Quality ID #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease National Quality Strategy Domain: Effective Clinical Care

Quality ID #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease National Quality Strategy Domain: Effective Clinical Care Quality ID #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Clinical Policy: Ezetimibe (Zetia) Reference Number: CP.PMN.78 Effective Date: Last Review Date: 02.19

Clinical Policy: Ezetimibe (Zetia) Reference Number: CP.PMN.78 Effective Date: Last Review Date: 02.19 Clinical Policy: (Zetia) Reference Number: CP.PMN.78 Effective Date: 02.01.17 Last Review Date: 02.19 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Vytorin) Reference Number: CP.PMN.77 Effective Date: 02.01.17 Last Review Date: 02.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy

More information

Crestor and thyroid problems

Crestor and thyroid problems Recently it has been observed that many people on statins have been referred for special radioiodine studies because they have been found to have low to no thyroid stimulating hormone (TSH) in their blood

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Statin Therapy Page 1 of 10 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Statin Therapy Prime Therapeutics will review Prior Authorization requests. Prior Authorization

More information

Cardiovascular Drugs and Therapies HMG CoA a REDUCTASE INHIBITORS (available in Canada)

Cardiovascular Drugs and Therapies HMG CoA a REDUCTASE INHIBITORS (available in Canada) Trade Name Dosage Forms 10 mg, 20 mg, 40 mg, 80 mg tablets Dosing Range 10-80 mg once daily 2 Dosing Based on Desired LDL Reduction 1,2,3 HMG CoA a REDUCTASE INHIBITORS (available in Canada) LIPITOR, generics

More information

Repatha. Repatha (evolocumab) Description

Repatha. Repatha (evolocumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.16.08 Subject: Repatha Page: 1 of 8 Last Review Date: September 18, 2015 Repatha Description Repatha

More information

Pravastatin 40mg convert to lipitor

Pravastatin 40mg convert to lipitor Pravastatin 40mg convert to lipitor 05/28/2017 Samantha brown fakes 05/28/2017 Olive garden employee schedules 05/30/2017 -Losertown weight loss calculator -Social skills bingo game printable 05/31/2017

More information

Convert rosuvastatin to atorvastatin

Convert rosuvastatin to atorvastatin Convert atorvastatin 11/01/2017 Is there any sulfur in sucralfate 11/03/2017 Hacked papa games unblocked 11/05/2017 -Gabapentin abuse snorting -Lowes permethrin spray 11/07/2017 Women castrating men topix

More information

Lipid Management Step Therapy Criteria with Medical Diagnoses Option*

Lipid Management Step Therapy Criteria with Medical Diagnoses Option* Lipid Management Step Therapy Criteria with Medical Diagnoses Option* * Medical diagnoses are required for implementation of this option. Program may be implemented with the following options: Option One

More information

Drug Class Review HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin

Drug Class Review HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin Drug Class Review HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin Final Report Update 5 November 2009 This report reviews information about the comparative

More information

Repatha. Repatha (evolocumab) Description

Repatha. Repatha (evolocumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.08 Subject: Repatha Page: 1 of 8 Last Review Date: December 2, 2016 Repatha Description Repatha (evolocumab)

More information

1.* Dosage. A. Adults

1.* Dosage. A. Adults 3-Hydroxy-3-Methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors [Developed, November 1994; Revised, October 1996; September 1997; September 1998; October 1999; November 1999; August 2000; September

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: CP.HNMC.05 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy for important

More information

High ( 50%) Restrictions mg 20-40mg Simvastatin (Zocor) 10mg 20-40mg $1.66 Pravastatin (Pravachol) mg $6.

High ( 50%) Restrictions mg 20-40mg Simvastatin (Zocor) 10mg 20-40mg $1.66 Pravastatin (Pravachol) mg $6. MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Cholesterol P&T DATE: 5/8/2018 THERAPEUTIC CLASS: Cardiovascular REVIEW HISTORY: 5/17, 5/16, 5/15, 2/14, LOB AFFECTED: Medi-Cal

More information

PATIENT INFORMATION. Medicine To Treat: C ardiac Diseases. Lipid-Lowering Medicines. Statins Fibrates Fat Binding Agents Nicotinic Acid Group

PATIENT INFORMATION. Medicine To Treat: C ardiac Diseases. Lipid-Lowering Medicines. Statins Fibrates Fat Binding Agents Nicotinic Acid Group PATIENT INFORMATION Medicine To Treat: C ardiac Diseases Lipid-Lowering Medicines Statins Fibrates Fat Binding Agents Nicotinic Acid Group ABOUT YOUR MEDICINE Your doctor has just prescribed for you: Medicine

More information

CRESTOR rosuvastatin calcium tablets

CRESTOR rosuvastatin calcium tablets PART III CONSUMER INFORMATION CRESTOR rosuvastatin calcium tablets This leaflet is part of a "Product Monograph" published when CRESTOR was approved for sale in Canada and is designed specifically for

More information

Cholesterol. Medicines To Help You

Cholesterol. Medicines To Help You Medicines To Help You Cholesterol Use this guide to help you talk to your doctor, pharmacist, or nurse about your cholesterol medicines. The guide lists all of the FDA-approved products now available to

More information

Doctor discussion guide:

Doctor discussion guide: Doctor discussion guide: MAnaging Cholesterol Bring this printout to your next doctor s appointment. It will help you and your doctor work together to set goals for treatment, evaluate the success of your

More information

Doctor discussion guide:

Doctor discussion guide: Bring this printout to your next doctor s appointment. It will help you and your doctor work together to set goals for treatment, evaluate the success of your treatment, and reduce your risk of side effects.

More information

Uniform Formulary Decisions 9 January 2014

Uniform Formulary Decisions 9 January 2014 Beneficiary Advisory Panel Handout Uniform Formulary Decisions 9 January 2014 Purpose: The purpose of this handout is to provide the BAP members with a reference document for the clinical effective presentation

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION ROSUVASTATIN-5 ROSUVASTATIN-10 ROSUVASTATIN-20 ROSUVASTATIN-40 Rosuvastatin Calcium Tablets This leaflet is part of a oduct Monograph published when ROSUVASTATIN was approved

More information

How would you manage Ms. Gold

How would you manage Ms. Gold How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56

More information

Clinical Policy: Lomitapide (Juxtapid) Reference Number: ERX.SPA.170 Effective Date:

Clinical Policy: Lomitapide (Juxtapid) Reference Number: ERX.SPA.170 Effective Date: Clinical Policy: (Juxtapid) Reference Number: ERX.SPA.170 Effective Date: 01.11.17 Last Review Date: 11.17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

Pharmacy Costs: Can I Make a Difference?

Pharmacy Costs: Can I Make a Difference? Pharmacy Costs: Can I Make a Difference? Pharmaceutical Market Dynamics What is driving Rx cost up? No New Blockbusters Patent Expirations OTC Market Dynamics Availability Pharmaceutical Companies Unfortunately,

More information

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Pharmacy Coverage Guidelines are subject to change as new information becomes available. Ezetimibe-simvastatin 10-80 mg oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy

More information

Clinical Policy: Mipomersen (Kynamro) Reference Number: ERX.SPA.171 Effective Date:

Clinical Policy: Mipomersen (Kynamro) Reference Number: ERX.SPA.171 Effective Date: Clinical Policy: (Kynamro) Reference Number: ERX.SPA.171 Effective Date: 01.11.17 Last Review Date: 08.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

CHOLESTEROL REDUCING MEDICATIONS. Five Main Categories. 1. Statins 2. Fibrates 3. Resins 4. Niacin 5. Cholesterol absorption inhibitor

CHOLESTEROL REDUCING MEDICATIONS. Five Main Categories. 1. Statins 2. Fibrates 3. Resins 4. Niacin 5. Cholesterol absorption inhibitor Page 1 of 5 PHA-GEN-002-2004 CHOLESTEROL REDUCING MEDICATIONS Five Main Categories 1. Statins 2. Fibrates 3. Resins 4. Niacin 5. Cholesterol absorption inhibitor Statins Also called HMG-CoA reductase inhibitors

More information

Scientific conclusions

Scientific conclusions Annex II Scientific conclusions and grounds for amendment of the summary of product characteristics, labelling and package leaflet presented by the European Medicines Agency 24 Scientific conclusions Overall

More information

Atorvastatin route of administration

Atorvastatin route of administration Atorvastatin route of administration 8-3-2017 Atorvastatin Calcium. Atorvastatin Calcium Combinations; Routes.. Petrella G et al. Effects of simvastatin and atorvastatin administration on. 1-3-2017 Atorvastatin

More information

Managed Care Trends in Statin Usage GARY R. BAZALO, MS, MBA

Managed Care Trends in Statin Usage GARY R. BAZALO, MS, MBA PHARMACY UTILIZATION Managed Care Trends in Statin Usage GARY R. BAZALO, MS, MBA ABSTRACT Purpose HMG-CoA reductase inhibitors ( statins ) have become the drug class of choice for the treatment of hyperlipidemia.

More information

Simvastatin 40 mg equivalent

Simvastatin 40 mg equivalent Simvastatin 40 mg equivalent 03/17/2018 Get on top 2 player kongregate 03/17/2018 How much can you earn with ss 03/19/2018 -The fox and friends weekend show after show -Electronic cigarette japan 03/21/2018

More information

Investor Presentation

Investor Presentation Investor Presentation May 1, 2018 Albert Friesen Chair, President & CEO James Kinley CFO Forward Looking Statement This presentation is for informational purposes only and should not be considered as an

More information

Pharmacy Drug Class Review

Pharmacy Drug Class Review Pharmacy Drug Class Review January 22, 2014 Authored By: Christina Manciocchi, Pharm.D. BCACP Disclaimer: Specific agents may have variations Edited By: Richard J. Kraft, Pharm.D.BCPS NEW CHOLESTEROL GUIDELINES

More information

Joshua Shepherd PA-C, MMS, MT (ASCP)

Joshua Shepherd PA-C, MMS, MT (ASCP) Joshua Shepherd PA-C, MMS, MT (ASCP) None What is Cholesterol? Why cholesterol is it important? Review the National Cholesterol Education Programs guidelines (NCEP-ATPIII) Discuss New guidelines from the

More information

Repatha. Repatha (evolocumab) Description

Repatha. Repatha (evolocumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.08 Subject: Repatha Page: 1 of 9 Last Review Date: September 15, 2017 Repatha Description Repatha

More information

Repatha. Repatha (evolocumab) Description

Repatha. Repatha (evolocumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.08 Subject: Repatha Page: 1 of 9 Last Review Date: November 30, 2018 Repatha Description Repatha (evolocumab)

More information

Atorvastatin 40 Mg Cost

Atorvastatin 40 Mg Cost Atorvastatin 40 Mg Cost lipitor 20 mg atorvastatin Free Coupons For Benicar Custa Xenical Manipulado atorvastatin 20 mg tablet price what is atorvastatin calcium tablets ip atorvastatin 40 mg tabletta

More information

Drug Use Criteria: 3-Hydroxy-3-Methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors (Statins)

Drug Use Criteria: 3-Hydroxy-3-Methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors (Statins) Texas Vendor Program Use Criteria: 3-Hydroxy-3-Methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors (Statins) Publication History Developed November 1994. Revised March 2018; March 2017; December 2014;

More information

Parker & Waichman, LLP Attorneys at Law CRESTOR Information Guide

Parker & Waichman, LLP Attorneys at Law CRESTOR Information Guide Parker & Waichman, LLP Attorneys at Law CRESTOR Information Guide The Case Against CRESTOR: Kidney Problems & Rhabdomyolysis Crestor has been linked to serious side effects including: kidney damage, kidney

More information

Praluent. Praluent (alirocumab) Description

Praluent. Praluent (alirocumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.06 Subject: Praluent Page: 1 of 10 Last Review Date: September 20, 2018 Praluent Description Praluent

More information

BRITISH BIOMEDICAL BULLETIN

BRITISH BIOMEDICAL BULLETIN Journal Home Page www.bbbulletin.org BRITISH BIOMEDICAL BULLETIN Original Cost Analysis Study of HMG CoA Inhibitors Sirisha A.* Department of Pharmacology, Kamineni Institute of Medical Sciences, Narketpally,

More information

Issue date: January Review date: November Statins for the prevention of cardiovascular events. Technology Appraisal 94

Issue date: January Review date: November Statins for the prevention of cardiovascular events. Technology Appraisal 94 Issue date: January 2006 Review date: November 2008 Statins for the prevention of cardiovascular events Technology Appraisal 94 Technology Appraisal 94 Statins for the prevention of cardiovascular events

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr CADUET (amlodipine besylate and atorvastatin calcium tablets) This leaflet is Part III of a three-part "Product Monograph" published when CADUET was approved for sale

More information

Understanding Your Patient Care Opportunity Report (PCOR)

Understanding Your Patient Care Opportunity Report (PCOR) Understanding Your Patient Care Opportunity Report (PCOR) Use your January/February 208 PCOR to help improve performance on Medicare Part D Clinical Star Ratings measures. Your January/February 208 Patient

More information

Spending in the United States for prescription drugs was $216.7

Spending in the United States for prescription drugs was $216.7 Lipid Profile Changes Associated With Changing Available Formulary Statins: Removing Higher Potency Agents Daniel S. Longyhore, PharmD; Casey McNulty Stockton, PharmD; and Marie Roke Thomas, PhD Spending

More information

What do the guidelines say about combination therapy?

What do the guidelines say about combination therapy? What do the guidelines say about combination therapy? Christie M. Ballantyne, MD Center for Cardiovascular Disease Prevention Methodist DeBakey Heart & Vascular Center Baylor College of Medicine Houston,

More information

Coronary heart disease is the leading cause of death in

Coronary heart disease is the leading cause of death in PHARMACOLOGY NOTES Ezetimibe (Zetia): a new type of lipid-lowering agent JIGNA PATEL, PHARMD CANDIDATE, VALERIE SHEEHAN, PHARMD, AND CHERYLE GURK-TURNER, RPH Coronary heart disease is the leading cause

More information

Achieving Lipid Goals: 2008 Update. Laura Hansen, Pharm.D. Associate Professor, University of Colorado School of Pharmacy

Achieving Lipid Goals: 2008 Update. Laura Hansen, Pharm.D. Associate Professor, University of Colorado School of Pharmacy Achieving Lipid Goals: 2008 Update Laura Hansen, Pharm.D. Associate Professor, University of Colorado School of Pharmacy Discuss relationship between lipid values and coronary events Evaluate clinical

More information

Proposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe

Proposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe 26 April 2010 Proposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe PHARMAC is seeking feedback on the following proposals relating to the cholesterol lowering pharmaceuticals

More information

Evaluating statin drugs to treat: High Cholesterol and Heart Disease Comparing Effectiveness, Safety, and Price

Evaluating statin drugs to treat: High Cholesterol and Heart Disease Comparing Effectiveness, Safety, and Price Evaluating statin drugs to treat: High Cholesterol and Heart Disease Comparing Effectiveness, Safety, and Price Contents Our Recommendations........................................... 3 Welcome....................................................

More information

Setting The study setting was secondary care. The economic analysis was conducted in the UK.

Setting The study setting was secondary care. The economic analysis was conducted in the UK. Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial Hirsch M, O'Donnell

More information

Pharmaceutical Help to Control Cholesterol

Pharmaceutical Help to Control Cholesterol Pharmaceutical Help to Control Cholesterol Catherine E. Cooke, PharmD, BCPS, PAHM President, PosiHealth, Inc. Clinical Associate Professor, Univ. of Maryland This program has been brought to you by PharmCon

More information

Drug Class Review on HMG-CoA Reductase Inhibitors (Statins)

Drug Class Review on HMG-CoA Reductase Inhibitors (Statins) Drug Class Review on HMG-CoA Reductase Inhibitors (Statins) August 2006 Original Report Date: April 2002 Update 1 Report Date: July 2003 Update 2 Report Date: June 2004 Update 3 Report Date: September

More information

Clinical Policy: Lomitapide (Juxtapid) Reference Number: ERX.SPA.170 Effective Date:

Clinical Policy: Lomitapide (Juxtapid) Reference Number: ERX.SPA.170 Effective Date: Clinical Policy: (Juxtapid) Reference Number: ERX.SPA.170 Effective Date: 01.11.17 Last Review Date: 08.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

Drug Class Review on HMG-CoA Reductase Inhibitors (Statins)

Drug Class Review on HMG-CoA Reductase Inhibitors (Statins) Drug Class Review on HMG-CoA Reductase Inhibitors () Final Report June 2004 Mark Helfand, MD, MPH Susan Carson, MPH Cathy Kelley, PharmD Oregon Evidence-based Practice Center Oregon Health & Science University

More information

Medications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy

Medications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy Medications for Type 2 Diabetes CDE Exam Preparation Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy Competency for CDE Exam 3.1.A Oral Medications for Type 2 Diabetes

More information

Your cholesterol levels. Questions or concerns

Your cholesterol levels. Questions or concerns Because you have high cholesterol you should: Know your cholesterol levels Take the medicine to lower cholesterol that your doctor has told you to take Follow your doctor s treatment plan Keep your appointments

More information

How to use statins in patients with chronic liver disease

How to use statins in patients with chronic liver disease REVIEW CME CREDIT MARK W. RUSSO, MD Center for the Study of Hepatitis C, Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY IRA M. JACOBSON, MD Center for the Study

More information

MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa

MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa PHARMACY POLICY & PROCEDURES Policy Number: 3.26 Subject: Purpose: Policy: Formulary Management through Establishing Guidelines, Policies or Therapeutic

More information

MOLINA HEALTHCARE OF CALIFORNIA

MOLINA HEALTHCARE OF CALIFORNIA MOLINA HEALTHCARE OF CALIFORNIA HIGH BLOOD CHOLESTEROL IN ADULTS GUIDELINE Molina Healthcare of California has adopted the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel

More information

In 2001, the National Cholesterol Education Program

In 2001, the National Cholesterol Education Program At a Glance Practical Implications p 330 Author Information p 333 Full text and PDF www.ajpblive.com Lipid Management When Converting Fluvastatin to Pravastatin: Medication Use Evaluation Original Research

More information

UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008

UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008 UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008 Promoting high quality, cost effective drug therapy throughout the Military Health System UF Decisions, May 07 Class FY05 rank, total $

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Kynamro) Reference Number: CP.PHAR.284 Effective Date: 10.16 Last Review Date: 02.19 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy

More information

Pitavastatin (Livalo) for Hyperlipidemia And Mixed Dyslipidemia

Pitavastatin (Livalo) for Hyperlipidemia And Mixed Dyslipidemia Pitavastatin (Livalo) for Hyperlipidemia And Mixed Dyslipidemia A Novel Therapeutic Agent, or a Me-Too Drug? Timothy Reilly, PharmD, BCPS; George King; Jee Hye Park; and Amanda Tracy INTRODUCTION Hyperlipidemia

More information

Generic Rosuvastatin 20 Mg

Generic Rosuvastatin 20 Mg Generic Rosuvastatin 20 Mg rosuvastatin online uk rosuvastatin calcium generic price crestor 20 mg tablet price rosuvastatin 10 mg india buy crestor 10mg online crestor rosuvastatin 10 mg crestor price

More information

Slide 1. Slide 2. Slide 3 STATINS & THE PLACEBO EFFECT K.C. KALTENBORN, M.D OBJECTIVES STATINS & THE PLACEBO EFFECT

Slide 1. Slide 2. Slide 3 STATINS & THE PLACEBO EFFECT K.C. KALTENBORN, M.D OBJECTIVES STATINS & THE PLACEBO EFFECT Slide 1 STATINS & THE PLACEBO EFFECT K.C. KALTENBORN, M.D. 2016 Slide 2 OBJECTIVES Examine Data that half of statin discontinuation is not due to a drug effect. Other Explanations for discontinuation Implications

More information

Clinical Policy: Step Therapy Reference Number: CP.PST.01 Effective Date: Last Review Date: 02.19

Clinical Policy: Step Therapy Reference Number: CP.PST.01 Effective Date: Last Review Date: 02.19 Clinical Policy: Reference Number: CP.PST.01 Effective Date: 12.28.17 Last Review Date: 02.19 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important regulatory

More information

DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INTERIM MEETING

DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INTERIM MEETING DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INTERIM MEETING Addendum December 17, 2013 I. UNIFORM FORMULARY (UF) DRUG CLASS REVIEWS A. Anti-Lipidemic-ls (LIP-ls) Background-New

More information

IMPORTANT: PLEASE READ What GD-amlodipine/atorvastatin does: PART III: CONSUMER INFORMATION Pr GD-amlodipine/atorvastatin

IMPORTANT: PLEASE READ What GD-amlodipine/atorvastatin does: PART III: CONSUMER INFORMATION Pr GD-amlodipine/atorvastatin PART III: CONSUMER INFORMATION Pr GD-amlodipine/atorvastatin (amlodipine besylate and atorvastatin calcium tablets) This leaflet is Part III of a three-part "Product Monograph" published when GDamlodipine/atorvastatin

More information

Setting The setting was secondary care. The economic study was carried out in the USA.

Setting The setting was secondary care. The economic study was carried out in the USA. Cost-effectiveness analysis of combination statin/ezetimibe therapy for the treatment of elevated low-density lipoprotein cholesterol Gryskiewicz K A, Coleman C I, Gillespie E L, White C M Record Status

More information

Medications for Treating Stroke

Medications for Treating Stroke Medications for Treating Stroke Subject Expert Sonny Kupniewski, PharmD, BCPS Swedish Medical Center Englewood, CO 2 Objectives Medications used to prevent stroke Prevention of strokes in patients with

More information

Acute Coronary Syndromes (ACS)

Acute Coronary Syndromes (ACS) Sally A. Arif, Pharm.D., BCPS (AQ Cardiology) Assistant Professor of Pharmacy Practice Midwestern University, Chicago College of Pharmacy Cardiology Clinical Specialist, Rush University Medical Center

More information

Hyperlipidemia: Past and Present. Rebecca Khaimova, PharmD The Brooklyn Hospital Center

Hyperlipidemia: Past and Present. Rebecca Khaimova, PharmD The Brooklyn Hospital Center Hyperlipidemia: Past and Present Rebecca Khaimova, PharmD The Brooklyn Hospital Center Rkhaimova@tbh.org Conflicts of Interest None to disclose Learning Objectives for Pharmacist Describe the pathophysiology

More information

A Review: Atherosclerosis & its treatment

A Review: Atherosclerosis & its treatment 73 Review Article A Review: Atherosclerosis & its treatment Yogesh K. Patil* Department of Pharmacology, Shree Mahavir Institute of Pharmacy, Nashik, Maharashtra, India *yogesh_kpatil85@yahoo.co.in ABSTRACT

More information

Step One Foods Definitive Guide to Cholesterol and Statins

Step One Foods Definitive Guide to Cholesterol and Statins STEPONEFOODS.COM Step One Foods Definitive Guide to Cholesterol and Statins About the Author Dr. Klodas is a cardiologist and founder of Step One Foods. She trained at Mayo Clinic and Johns Hopkins, and

More information

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines Conflict of Interest Disclosure Updates for the Ambulatory Care Pharmacist: Dyslipidemia and CV Risk Assessment No conflicts of interest to disclose 2014 Updates to the Updates in Ambulatory Care Pharmacy

More information

NICE QIPP about Lipitor. Robert Trotter. Clinical Effectiveness Consultant

NICE QIPP about Lipitor. Robert Trotter. Clinical Effectiveness Consultant NICE QIPP about Lipitor Robert Trotter Clinical Effectiveness Consultant LIP2894c Date of preparation: April 2009 Prescribing information for atorvastatin is available on the last slide Roadmap Background

More information

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia PIEDMONT ACCESS TO HEALTH SERVICES, INC. Policy Number: 01-09-021 SUBJECT: Guidelines for Screening and Management of Dyslipidemia EFFECTIVE DATE: 04/2008 REVIEWED/REVISED: 04/12/10, 03/17/2011, 4/10/2012,

More information

Mediscor Medicines Review 2011

Mediscor Medicines Review 2011 Mediscor Medicines Review 2011 Mediscor Client Workshop 2012 28 August 2012 Presented by: Madelein Bester Benefit Management Mediscor PBM Content Background of the report Overall trends Expenditure per

More information

Disclosures No relationships (not even to an employer) No off-label uses. Cholesterol Lowering Guidelines: What now?

Disclosures No relationships (not even to an employer) No off-label uses. Cholesterol Lowering Guidelines: What now? Disclosures No relationships (not even to an employer) No off-label uses Cholesterol Lowering Guidelines: What now?, FACP 1 2 65-year-old white woman Total cholesterol 175mg/dL HDL 54 mg/dl LDL 96 mg/dl

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 6 October 2010

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 6 October 2010 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 6 October 2010 CRESTOR 5 mg, film-coated tablet B/30 (CIP code: 369 853-8) B/90 (CIP code: 391 690-0) CRESTOR 10 mg,

More information

High levels of cholesterol lead to an accretion

High levels of cholesterol lead to an accretion 2009 Drug Utilization and Cost Trends in Lipid-Lowering Agents Drug Trends Anna A. Theodorou, RPh, MBA; Kelly M. Johnson, MBA; and John A. Szychowski, AAS, BS High levels of cholesterol lead to an accretion

More information